Mammography Screening Frequency for a 67-Year-Old Woman
A 67-year-old woman in good health should undergo screening mammography every 1-2 years, with annual screening providing greater mortality reduction than biennial screening.
Recommended Screening Interval
At age 67, you fall into the 55+ age category where guidelines offer flexibility between annual and biennial screening based on individual circumstances and preferences 1, 2.
Annual vs. Biennial Screening: The Evidence
Annual screening is superior for mortality reduction:
- Annual mammography reduces breast cancer mortality by 40% (saving 12 lives per 1,000 women screened)
- Biennial screening reduces mortality by only 32% for ages 40-84, and just 23% for ages 50-74 (saving 7 lives per 1,000 women screened) 2
The trade-offs:
- More frequent screening means more false-positive recalls (approximately 10% of screening mammograms result in recall, though <2% lead to biopsy recommendations) 2
- Over 10 years of screening, about 200 per 1,000 women will experience false-positive results 3
- However, research shows women value early cancer detection over the anxiety from false-positives 2
Key Considerations at Your Age
Continue screening as long as:
- You remain in overall good health
- You have a life expectancy of ≥10 years 1, 2, 3
- You are willing to undergo additional testing or biopsy if an abnormality is found
There is no upper age limit for screening mammography 2. Observational studies demonstrate that women ≥75 years continue to benefit from screening, though randomized trials did not enroll women over age 74 2.
Guideline Differences Explained
The 2015 American Cancer Society guidelines recommend transitioning to biennial screening at age 55, with the option to continue annually 1. However, the most recent 2025 ACR Appropriateness Criteria strongly recommend annual screening for all average-risk women starting at age 40 and continuing as long as they remain healthy 2.
The ACR's position is based on:
- Annual screening detecting smaller tumors (average 10.7 mm vs. 16.5 mm for biennial) 4
- Significantly less advanced disease with annual screening (72% minimal disease vs. 44% with biennial) 4
- Higher frequency of interval cancers with biennial screening 2
Clinical Bottom Line
For a healthy 67-year-old woman, annual mammography provides the greatest mortality benefit and detects cancers at earlier, more treatable stages. If you prefer to reduce the frequency of screening and accept a somewhat higher risk of interval cancers and later-stage detection, biennial screening remains a reasonable option. This decision should factor in your overall health status, life expectancy, personal values regarding the balance of benefits and harms, and whether you have additional risk factors like extremely dense breasts.